NotesFAQContact Us
Collection
Advanced
Search Tips
Showing 1 to 15 of 17 results Save | Export
Sleep-Related Problems among Children and Adolescents with Anxiety Disorders
Peer reviewed Peer reviewed
Direct linkDirect link
Alfano, Candice A.; Ginsburg, Golda S.; Kingery, Julie Newman – Journal of the American Academy of Child and Adolescent Psychiatry, 2007
Objective: The present study examined sleep-related problems (SRPs) among a large sample (n = 128) of youth with anxiety disorders (i.e., generalized, separation, and social). The frequency of eight specific SRPs was examined in relation to age, gender, type of anxiety disorder, anxiety severity, and functional impairment. The impact of…
Descriptors: Severity (of Disability), Pharmacology, Adolescents, Anxiety
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
Peer reviewed Peer reviewed
Direct linkDirect link
Van der Heijden, Kristiaan B.; Smits, Marcel G.; Van Someren, Eus J. W.; Ridderinkhof, K. Richard; Gunning, W. Boudewijn – Journal of the American Academy of Child and Adolescent Psychiatry, 2007
Objective: To investigate the effect of melatonin treatment on sleep, behavior, cognition, and quality of life in children with attention-deficit/hyperactivity disorder (ADHD) and chronic sleep onset insomnia. Method: A total of 105 medication-free children, ages 6 to 12 years, with rigorously diagnosed ADHD and chronic sleep onset insomnia…
Descriptors: Quality of Life, Hyperactivity, Body Weight, Sleep
Actigraphic Monitoring during Sleep of Children with ADHD on Methylphenidate and Placebo
Peer reviewed Peer reviewed
Schwartz, George; Amor, Leila Ben; Grizenko, Natalie; Lageix, Philippe; Baron, Chantal; Boivin, Diane B.; Joober, Ridha – Journal of the American Academy of Child and Adolescent Psychiatry, 2004
Objective: Sleep disturbances appear as a comorbid condition in children with attention-deficit/hyperactivity disorder. The aim of this study was to investigate the relationship of activity levels during sleep and therapeutic response to methylphenidate (MPH). Method: Nightly sleep actigraphic recordings during a double-blind, placebo-controlled,…
Descriptors: Psychiatry, Sleep, Hyperactivity, Attention Deficit Disorders
Parental Perception of Sleep Problems in Children of Normal Intelligence with Pervasive Developmental Disorders: Prevalence, Severity, and Pattern
Peer reviewed Peer reviewed
Couturier, Jennifer L.; Speechley, Kathy N.; Steele, Margaret; Norman, Ross; Stringer, Bernadette; Nicolson, Rob – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
Objective: This study compares parents' perceptions of the prevalence, severity, and pattern of sleep problems in children of normal intelligence with pervasive developmental disorders (PDDs) with a normative comparison group of children. Method: A survey including the Children's Sleep Habits Questionnaire was mailed to a sample of parents of…
Descriptors: Severity (of Disability), Psychiatry, Parents, Incidence
Etiologies of Associations between Childhood Sleep and Behavioral Problems in a Large Twin Sample.
Peer reviewed Peer reviewed
Gregory, Alice M.; Eley, Thalia C.; O'Connor, Thomas G.; Plomin, Robert – Journal of the American Academy of Child and Adolescent Psychiatry, 2004
Objective: To examine the etiologies of covariation of childhood sleep problems and other behavioral/emotional problems in young children. Method: The parents of more than 6,000 twin pairs provided information on their twins' anxiety, conduct, and hyperactivity at ages 3, 4, and 7 by completing the Strengths and Difficulties Questionnaire.…
Descriptors: Organizations (Groups), Psychiatry, Heredity, Emotional Problems
Pharmacological Management of Treatment-Induced Insomnia in ADHD
Peer reviewed Peer reviewed
Kratochvil, Christopher J.; Lake, Marybeth; Pliszka, Steven R.; Walkup, John T. – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
A 7-year-old girl with attention-deficit/hyperactivity disorder (ADHD), combined subtype, and oppositional defiant disorder presents with a complaint of marked insomnia. Her parents describe 60 to 90 minutes of nightly initial insomnia that began with the initiation of 36 mg OROS methylphenidate (Concerta) 2 months ago. Behavioral interventions…
Descriptors: Drug Therapy, Stimulants, Sleep, Hyperactivity
A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Peer reviewed Peer reviewed
Direct linkDirect link
Greenhill, Laurence L.; Biederman, Joseph; Boellner, Samuel W.; Rugino, Thomas A.; Sangal, R. Bart; Earl, Craig Q.; Jiang, John G.; Swanson, James M. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To evaluate the efficacy and tolerability of modafinil in children and adolescents, ages 7 to 17, with attention-deficit/hyperactivity disorder (ADHD). Method: In this 9-week, double-blind, flexible-dose study, patients were randomized to once-daily modafinil (170-425 mg) or placebo. Assessments included ADHD Rating Scale-IV…
Descriptors: Patients, Adolescents, Hyperactivity, Attention Deficit Disorders
Subjective Sleep Complaints in Pediatric Depression: A Controlled Study and Comparison with EEG Measures of Sleep and Waking
Peer reviewed Peer reviewed
Bertocci, Michele A.; Dahl, Ronald E.; Williamson, Douglas E.; Iosif, Ana-Maria; Birmaher, Boris; Axelson, David; Ryan, Neal D. – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
Objective: Children with major depressive disorder (MDD) often complain of sleep disturbances; however, polysomnographic studies have failed to find objective evidence of these disturbances. This article examines subjective sleep reports of children with MDD and healthy controls focusing on comparing subjective and objective sleep measures.…
Descriptors: Psychiatry, Depression (Psychology), Sleep, Medicine
Somatic Symptoms in Children and Adolescents with Anxiety Disorders
Peer reviewed Peer reviewed
Direct linkDirect link
Ginsburg, Golda S.; Riddle, Mark A.; Davies, Mark – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To evaluate the prevalence of somatic symptoms (SSs) in children and adolescents with anxiety disorders; the relationship between SSs and anxiety severity, impairment, and child global functioning; and the impact of fluvoxamine (FLV) versus pill placebo (PBO) on reducing SSs. Method: As part of a double-blind, placebo-controlled trial,…
Descriptors: Severity (of Disability), Adolescents, Rating Scales, Anxiety
Sleep Hygiene and Melatonin Treatment for Children and Adolescents with ADHD and Initial Insomnia
Peer reviewed Peer reviewed
Direct linkDirect link
Weiss, Margaret D.; Wasdell, Michael B.; Bomben, Melissa M.; Rea, Kathleen J.; Freeman, Roger D. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To evaluate the efficacy of sleep hygiene and melatonin treatment for initial insomnia in children with attention-deficit/hyperactivity disorder (ADHD). Method: Twenty-seven stimulant-treated children (6-14 years of age) with ADHD and initial insomnia (greater than 60 minutes) received sleep hygiene intervention. Nonresponders were…
Descriptors: Intervention, Hygiene, Stimulants, Hyperactivity
Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD
Peer reviewed Peer reviewed
Direct linkDirect link
Greenhill, Laurence; Kollins, Scott; Abikoff, Howard; McCracken, James; Riddle, Mark; Swanson, James; McGough, James; Wigal, Sharon; Wigal, Tim; Vitiello, Benedetto; Skrobala, Anne; Posner, Kelly; Ghuman, Jaswinder; Cunningham, Charles; Davies, Mark; Chuang, Shirley; Cooper, Tom – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: The Preschool ADHD Treatment Study (PATS) was a NIMH-funded, six-center, randomized, controlled trial to determine the efficacy and safety of immediate-release methylphenidate (MPH-IR), given t.i.d. to children ages 3 to 5.5 years with attention-deficit/hyperactivity disorder (ADHD). Method: The 8-phase, 70-week PATS protocol included…
Descriptors: Safety, Rating Scales, Hyperactivity, Effect Size
Safety and Tolerability of Methylphenidate in Preschool Children with ADHD
Peer reviewed Peer reviewed
Direct linkDirect link
Wigal, Tim; Greenhill, Laurence; Chuang, Shirley; McGough, James; Vitiello, Benedetto; Skrobala, Anne; Swanson, James; Wigal, Sharon; Abikoff, Howard; Kollins, Scott; McCracken, James; Riddle, Mark; Posner, Kelly; Ghuman, Jaswinder; Davies, Mark; Thorp, Ben; Stehli, Annamarie – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To report on the safety and tolerability of methylphenidate (MPH) 3- to 5-year-old children with attention-deficit/hyperactivity disorder (ADHD) during 1 year of treatment. Method: Exactly 183 children (3-5 years old) entered a treatment study of MPH, consisting of a 1-week open-label lead-in (n = 183); a 5-week placebo-controlled,…
Descriptors: Safety, Maintenance, Preschool Children, Hyperactivity
Case Study: Psychiatric Misdiagnosis of Non-24-Hours Sleep-Wake Schedule Disorder Resolved by Melatonin
Peer reviewed Peer reviewed
Dagan, Yaron; Ayalon, Liat – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
This case study describes a 14-year-old male suffering from significant academic and personal difficulties, who has been diagnosed with depression, schizotypal personality disorder, and learning disabilities. Because of excessive sleepiness, assessment for a potential sleep disorder was performed. An overnight polysomnographic study revealed no…
Descriptors: Psychological Patterns, Clinical Diagnosis, Sleep, Mental Disorders
Remission and Residual Symptoms after Short-Term Treatment in the Treatment of Adolescents with Depression Study (TADS)
Peer reviewed Peer reviewed
Direct linkDirect link
Kennard, Betsy; Silva, Susan; Vitiello, Benedetto; Curry, John; Kratochvil, Christopher; Simons, Anne; Hughes, Jennifer; Feeny, Norah; Weller, Elizabeth; Sweeney, Michael; Reinecke, Mark; Pathak, Sanjeev; Ginsburg, Golda; Emslie, Graham; March, John – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To ascertain remission rates in depressed youth participating in the Treatment for Adolescents With Depression Study (TADS), a multisite clinical trial that randomized 439 adolescents with major depressive disorder (MDD) to a 12-week treatment of fluoxetine (FLX), cognitive-behavioral therapy (CBT), their combination (COMB), or clinical…
Descriptors: Adolescents, Depression (Psychology), Outcomes of Treatment, Symptoms (Individual Disorders)
Treatment for Adolescents with Depression Study (TADS): Safety Results
Peer reviewed Peer reviewed
Direct linkDirect link
Emslie, Graham; Kratochvil, Christopher; Vitiello, Benedetto; Silva, Susan; Mayes, Taryn; McNulty, Steven; Weller, Elizabeth; Waslick, Bruce; Casat, Charles; Walkup, John; Pathak, Sanjeev; Rohde, Paul; Posner, Kelly; March, John – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO). Method: Safety assessments included adverse events (AEs) collected by spontaneous report, as well as systematic…
Descriptors: Safety, Patients, Adolescents, Suicide
Previous Page | Next Page ยป
Pages: 1  |  2